A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

Autor: Paz-Ares, Luis a, ∗, Vicente, David b, Tafreshi, Ali c, Robinson, Andrew d, Soto Parra, Hector e, Mazières, Julien f, Hermes, Barbara g, Cicin, Irfan h, Medgyasszay, Balazs i, Rodríguez-Cid, Jerónimo j, Okamoto, Isamu k, Lee, SungSook l, Ramlau, Rodryg m, Vladimirov, Vladimir n, Cheng, Ying o, Deng, Xuan p, Zhang, Ying q, Bas, Tuba p, Piperdi, Bilal p, Halmos, Balazs r
Zdroj: In Journal of Thoracic Oncology October 2020 15(10):1657-1669
Databáze: ScienceDirect